TOMI Environmental Solutions Receives $500,000 Order for SteraMist Integration from Global Biopharma Leader
Reuters
Dec 18, 2025
<a href="https://laohu8.com/S/TOMZ">TOMI Environmental</a> Solutions Receives $500,000 Order for SteraMist Integration from Global Biopharma Leader
TOMI Environmental Solutions Inc. announced that it has received a signed purchase contract and a purchase order valued at approximately $500,000 from a major global biopharmaceutical company. The order is for the full integration of TOMI's SteraMist Integrated Systems (SIS) platform into the client's manufacturing infrastructure, specifically for use in passthrough fill boxes within sterile manufacturing and advanced therapeutic production processes. The contract includes installation and performance qualification services to ensure compliance with biopharmaceutical regulatory requirements. The SIS platform, launched in late 2024, is designed for automated, high-throughput decontamination and is part of a broader pipeline of anticipated orders.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOMI Environmental Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9604492) on December 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.